Every first Sunday in June, communities across the country mark National Cancer Survivors Day. The day exists because one patient refused to accept his prognosis as a verdict.
In 1978, a man named Richard Bloch was told he had terminal lung cancer and three months to live.
He lived another 26 years.
In that time, he and his wife Annette built something that didn't exist before: a day dedicated to the idea that a cancer diagnosis is not a death sentence. They called it National Cancer Survivors Day. The first one was held in 1988, and the celebrations have continued every first Sunday in June since.
What's worth knowing about how it started is the why. Bloch wasn't trying to create a day about resilience in the abstract. He believed, based on his own experience and the patients he worked with afterward, that hope itself was a clinical factor. That patients who were told they had options, who were treated as still-living people rather than terminal cases, did better. He spent the rest of his life trying to bake that belief into the culture of cancer care.
National Cancer Survivors Day is, in a real sense, a patient-built intervention. It exists because one patient decided that other patients deserved to be treated like they had a future.
When the Bloch Cancer Foundation set up National Cancer Survivor Day, they made a deliberate choice about who qualified as a survivor. Not just people who finished treatment. Not just people in remission. Anyone living with a history of cancer, starting from the day they were diagnosed.
It's a small linguistic move that does a lot of work. It means a person in active chemotherapy is a survivor. A person with metastatic disease who will be in treatment for the rest of their life is a survivor. A person who got their pathology report yesterday is a survivor.
The definition reframes survival from an outcome you have to earn into a status you hold the moment you start fighting.
When National Cancer Survivors Day started in 1988, there were roughly 6 million cancer survivors in the United States.
Today there are about 18.6 million. By 2035, that number is expected to climb past 22 million.
The shift isn't because more people are getting cancer, though incidence has risen modestly. It's because more people are living with it longer. Earlier detection, better treatments, and an expanded definition of what cancer care looks like after the initial diagnosis have all changed the math.
A diagnosis in 2026 is not the diagnosis it was in 1988. The day, in that sense, is also a marker of progress, the kind that's measurable in human lifespans.
Read patient stories from the PatientWing community.
None of this means survivorship is easy. The day was never about pretending it was.
Long after active treatment ends, survivors deal with things the general public rarely sees. Late effects from chemotherapy or radiation that show up years later. Cognitive changes that don't always resolve. Cardiovascular and endocrine consequences of curative treatment. The mental load of every follow-up scan. The financial weight of bills that keep coming. The complicated work of explaining a cancer history to a new doctor, a new employer, a new partner.
Survivorship care, as a recognized subspecialty, is still relatively young. The National Academies of Sciences flagged the gap in a landmark 2005 report called From Cancer Patient to Cancer Survivor: Lost in Transition, and the field has spent two decades trying to catch up. Progress has been real but uneven. Where you live, what kind of cancer you had, and what insurance you carry still shape how well the after-care chapter goes.
This is part of what NCSD events are pushing on: not just celebrating survivors, but advocating for the systems that support them once the active treatment phase ends.
The Foundation lists hundreds of community events each year at ncsd.org. Many are open to the public.
Beyond attending, the most concrete things a non-survivor can do are practical. Donate to organizations doing survivorship research, like the American Cancer Society's Survivorship Center or the Lance Armstrong Foundation. Push for survivorship care plans to be standard in oncology practice. Learn the late effects associated with cancers your own family has a history of, so you can advocate for the screening that should follow.
And if there's a survivor in your life: a message on June 7 that names the day means more than a generic "thinking of you." It tells them you know what they've been carrying.
Richard Bloch died in 2004, 26 years after his "terminal" prognosis.
The day he and Annette built has outlived him by more than two decades, and it now reaches 18 million people who fit the definition he insisted on writing broadly.
That's the legacy. Not a feeling, but a definition. Not a slogan, but a count.
June 7 is for all of them.
National Cancer Survivors Day is observed every year on the first Sunday in June. In 2026, that falls on Sunday, June 7. The day was first held in 1988 and now reaches an estimated 18.6 million cancer survivors across the United States.
Several U.S. cancer foundations are widely recognized for their research, patient support, and impact on cancer care:
These organizations are well-rated by independent charity watchdogs and fund both research and patient support programs.
Multiple sclerosis (MS) is a chronic disease of the central nervous system (brain and spinal cord) that occurs when the immune system attacks the layer surrounding nerve cells, known as the myelin sheath. When myelin is lost, it damages nerves and disrupts communication between the brain and the rest of the body.
Learn More